Tenax Therapeutics (TENX) Operating Expenses: 2010-2016
Historic Operating Expenses for Tenax Therapeutics (TENX) over the last 3 years, with Dec 2016 value amounting to $42.2 million.
- Tenax Therapeutics' Operating Expenses was N/A to $42.2 million in Q4 2016 from the same period last year, while for Dec 2016 it was $58.6 million, marking a year-over-year change of. This contributed to the annual value of $19.5 million for FY2024, which is 136.75% up from last year.
- Per Tenax Therapeutics' latest filing, its Operating Expenses stood at $42.2 million for Q4 2016, which was up 838.22% from $4.5 million recorded in Q3 2016.
- In the past 5 years, Tenax Therapeutics' Operating Expenses registered a high of $75.7 million during Q2 2013, and its lowest value of $1.2 million during Q4 2012.
- Over the past 2 years, Tenax Therapeutics' median Operating Expenses value was $5.9 million (recorded in 2015), while the average stood at $14.7 million.
- In the last 5 years, Tenax Therapeutics' Operating Expenses plummeted by 44.28% in 2012 and then spiked by 3,764.46% in 2013.
- Quarterly analysis of 4 years shows Tenax Therapeutics' Operating Expenses stood at $1.2 million in 2012, then spiked by 3,764.46% to $75.7 million in 2013, then reached $6.2 million in 2015, then reached $42.2 million in 2016.
- Its Operating Expenses was $42.2 million in Q4 2016, compared to $4.5 million in Q3 2016 and $5.7 million in Q2 2016.